FINHUB Insights

LH · Q2 FY25 · Apr 1 – Jun 30, 2025

Labcorp Q2 FY25: where the revenue came from and where it went

Labcorp Q2 FY25: revenue $3.5B (+10% year over year). Net profit $0.2B. Largest cohort Diagnostics $2.7B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 1, 2025 10-Q
Sankey diagram of Labcorp's income statement for Q2 FY25: revenue of $3.5 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.5B +10% year over year
Gross profit$1B 30% margin
Operating profit$0.4B 11% margin
Net profit$0.2B 7% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 3.5 100% +10%
Diagnostics 2.7 77% +9%
Biopharma Laboratory 0.8 23% +11%
Cost of revenue−2.571%
Gross profit130% margin+1pp
SG&A−0.616%−1pp
Other−0.12%+0pp
Operating profit0.411% margin+2pp
Tax−0.1
Interest & other costs−0.1
Net profit0.27%+0pp
Filing on EDGAR More quarters of LH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters